As we reach the All-Star break, it's a perfect time to reflect on the first half of the fantasy baseball season and assess the performance of players we've been tracking. In this midseason review, we'll dive into the 'buy', 'sell', and 'hold' recommendations made earlier and explore how they've played out so far.
One thing that immediately stands out is the importance of player evaluation and the challenges it presents. With a mix of established veterans and up-and-coming talent, fantasy managers must navigate the fine line between recognizing potential and avoiding unsustainable hot streaks.
Let's start with the 'buy' recommendations and see how some of these players have performed.
Buy Recommendations
Caleb Durbin
A pleasant surprise, Durbin has shown an impressive ability to make contact and is on track for a solid 20-20 season. While his average may rise, there's a risk of regression, and his overall value might peak soon.
Jac Caglianone
Caglianone's power potential is intriguing, but his high strikeout rate is a concern. If he can improve his contact rate, he could become a consistent 40-home run threat.
Ivan Herrera
Herrera's recent struggles are a bit of a mystery. A potential fatigue factor could be at play, but his decreased bat speed is a cause for concern. I'd consider selling him at top-catcher value to avoid further risks.
Fernando Tatis
Tatis finally found his power stroke, and I believe he has more hot streaks in him. If his manager is losing patience, now might be the time to buy low.
Willson Contreras
I'm a big believer in Contreras, and his new approach is paying dividends. While there may be some downside to his current strategy, he's proven to be a consistent producer.
Carson Benge
Benge's expected stats suggest some upside, but his current numbers are more realistic. The steals are a nice bonus, but I'd be cautious about overvaluing him.
Dansby Swanson
Swanson is a 'hold' for me. He's not an exciting option, but he consistently racks up counting stats, which wRC+ may not fully capture.
Esmerlyn Valdez
Valdez's recent performance has been impressive, and I'm glad I stood by him. He's a great pickup if he's still available in your league.
Zack Gelof
My prediction about Gelof came true, but it's important to remember the limitations of small sample sizes. His recent cold stretch is a reminder that stats can be volatile.
Lars Nootbaar, Vladimir Guerrero, and Ketel Marte
These players fit my 'power plus contact' profile. Despite recent slumps, I still believe in their potential, especially with Guerrero and Marte's health concerns now behind them.
Sell Recommendations
Ian Happ
Happ's trade-off of power for contact is an interesting strategy, but his increased strikeout rate is a concern. I'd hold and bench him in 12-team leagues.
Andy Pages
Pages is a win for me, as his production dropped after I called him a sell. However, he's still a valuable asset in an elite lineup.
Xander Bogaerts
Bogaerts has lost his power, and I don't see much value beyond deep-league filler. It's a tough pill to swallow for the Padres, especially with his long-term contract.
Jazz Chisholm
Chisholm is a streaky player, and his steals keep his value afloat. I'd buy the dip if possible, as he has the potential to shine again.
Randy Arozarena
Arozarena remains a fantastic asset, but I don't see him maintaining a wRC+ over 140. His current average is likely more sustainable, and he still offers great value with his speed.
Liam Hicks
Hicks' lack of power is a mystery, but his bat control is impressive. I'd consider him a batting average specialist with some upside at catcher.
Otto Lopez and Owen Caissie
These Marlins hitters are proving me wrong. Caissie's power is exceptional, and if he can improve his K rate, he could be a 50-homer threat. Lopez's contact quality is impressive, but I'd be cautious about his long-term sustainability.
A.J. Ewing
Ewing's story is similar to Lopez's, and Statcast supports his performance so far. I'd hold onto him for now, as he has the potential to provide solid value.
CJ Abrams
Abrams is a polarizing figure, similar to Chisholm. I'd advise against believing either extreme version as the 'real' Abrams.
In conclusion, this midseason review highlights the challenges and rewards of fantasy baseball. It's a constant balancing act between recognizing potential and managing risk. As we head into the second half, I encourage you to continue 'buying' and 'holding' this column for more insightful analysis and recommendations.
